- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Latest News
BEIJING, - China rejected on Thursday a World Health Organization (WHO) plan for a second phase of an investigation into...
Read More
Read More
Close to 68 per cent of Indians aged over 6 years could have picked up the Covid-19 disease and recovered from it. So...
Read More
Read More
The effectiveness of AstraZeneca's viral vector vaccine against symptomatic infections caused by the variant was lower...
Read More
Read More
New Delhi: The European Union's reluctance in accepting Indian-made vaccines for its 'vaccination passport' has...
Read More
Read More
Washington: India's Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research,...
Read More
Read More
The U.S. Food and Drug Administration said on Wednesday it plans to move quickly to add a warning about rare cases of...
Read More
Read More
The Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) are set to conduct a study to...
Read More
Read More
‘eSanjeevani’ provides free video-based tele-consultation
Common Services Centres (CSC) and the Ministry...
Read More
Common Services Centres (CSC) and the Ministry...
Read More
The White House laid out a plan on Monday to share 55 million U.S. COVID-19 vaccine doses globally, with roughly 75% of...
Read More
Read More
Globally, the Variants of Concern and the opening of economies contributed to the recent surge in cases. The World...
Read More
Read More
SEOUL,(Reuters) - South Korea's SK bioscience (302440.KS) said on Monday it plans to expand vaccine production by...
Read More
Read More
Influenza H1N1 or Swine Flu is being reported in Mumbai amid ongoing Coronavirus pandemic in the country. Since the...
Read More
Read More